对加密素P450环氧化酶的分析揭示了基质耐受性和合作性
Yousong Ding1, Wolfgang H Seufert, Zachary Q Beck
1Life Sciences Institute and Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA.
Journal of the American Chemical Society
|March 28, 2008
概括
P450环氧化酶CrpE催化了产生强大的抗癌加密素的关键步骤. 这项研究描述了CrpE的特征.
科学领域:
- 生物化学 生物化学
- 自然产品 化学 化学
- 酶学 是一种酶学.
背景情况:
- 密码素是来自Nostoc蓝藻细菌的强效抗癌剂.
- 在C2'-C3'位置上的β-环氧化物对加密素的抗癌活性至关重要.
- P450环氧化酶,CrpE,负责安装这个关键的功能组.
研究的目的:
- 描述CrpE环氧酶的基质特异性和催化效率.
- 为了研究该酶在活性密码素类似物生物合成中的作用.
主要方法:
- 一种马尔托结合蛋白 (MBP) -CrpE融合蛋白的表达和净化.
- 化学酶合成加密素类似物以测试基质耐受性.
- 酶动力学 (kcat/Km) 和结合分析.
主要成果:
- 具体而言,CrpE在循环密码素类似物的C2'-C3'位置上安装β-环氧化物.
- 确定了动力参数 (kcat/Km),揭示了酶效率与基质结构的变化.
- 约束性分析表明MBP-CrpE与天然和非天然的脱氧密码素基质的合作性.
结论:
- CrpE环氧酶是加密素生物合成中的关键酶,具有很高的区域和立体特异性.
- 了解CrpE的基质耐受性可以指导新型抗癌剂的开发.
- 描述的P450环氧化酶为自然产品合成中环氧化物形成的催化机制提供了洞察力.
相关概念视频
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Acid-Catalyzed Ring-Opening of Epoxides
Epoxides that are three-membered ring systems are more reactive than other cyclic and acyclic ethers. The high reactivity of epoxides originates from the strain present in the ring. This ring strain acts as a driving force for epoxides to undergo ring-opening reactions either with halogen acids or weak nucleophiles in the presence of mild acid. The acid catalyst converts the epoxide oxygen, a poor leaving group, into an oxonium ion, a better leaving group, making the reaction feasible. The...
Base-Catalyzed Ring-Opening of Epoxides
Due to their highly strained structures, epoxides can readily undergo ring-opening reactions through nucleophilic substitution, either in the presence of an acid or a base. The nucleophilic substitution reactions in the presence of acid are called acid-catalyzed ring-opening reactions, and nucleophilic substitution reactions in the presence of a base are called base-catalyzed ring-opening reactions. Epoxides undergo base-catalyzed ring-opening reactions in the presence of a strong nucleophile...
Preparation of Epoxides
Overview
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy acids to...
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy acids to...
Sharpless Epoxidation
The conversion of allylic alcohols into epoxides using the chiral catalyst was discovered by K. Barry Sharpless and is known as Sharpless epoxidation. The use of a chiral catalyst enables the formation of one enantiomer of the product in excess. This chiral catalyst is mainly a chiral complex of titanium tetraisopropoxide and tartrate ester (specific stereoisomer). The stereoisomer used in the chiral catalyst dictates the formation of the enantiomer of the product. In other words, the use of...
Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...


